- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urothelial Tract/Bladder Cancer, Nos
Total 29159 results
-
Tianjin Medical University Cancer Institute and...Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsNot yet recruitingNeoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
-
Omar MianGilead Sciences; Varian IncRecruitingMuscle-Invasive Bladder Carcinoma | Localized Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
PfizerTerminatedNon-Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States
-
Jules Bordet InstituteEli Lilly and CompanyCompletedCholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCCFrance, Belgium
-
University of Rome Tor VergataUniversity Of Perugia; University of L'AquilaCompletedBladder Cancer TNM Staging Primary Tumor (T) Ta | Bladder Cancer TNM Staging Primary Tumor (T) T1 | Bladder Cancer Transitional Cell GradeItaly
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Central Hospital, Nancy, FranceNot yet recruitingHypospadias | Bladder, Neurogenic | Spina Bifida | Bladder Exstrophy | Urothelial Neoplasm
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Recruiting
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United Kingdom; National...RecruitingInvasive Bladder CancerUnited Kingdom
-
Institut BergoniéWyeth is now a wholly owned subsidiary of PfizerCompletedRelapsed Bladder CancerFrance
-
UNC Lineberger Comprehensive Cancer CenterCompletedInvasive Bladder CancerUnited States
-
Anchiano Therapeutics Israel Ltd.CompletedSuperficial Bladder CancerIsrael, United States
-
North Florida/South Georgia Veterans Health SystemAxcan Pharma; North Florida Foundation for Research and EducationCompletedSuperficial Bladder CancerUnited States
-
Eli Lilly and CompanyCompleted
-
Monika Joshi, MDPfizer; Eisai Inc.; Big Ten Cancer Research ConsortiumTerminatedMetastatic Urothelial Cell CancerUnited States
-
Zhujiang HospitalRecruiting
-
Jørgen Bjerggaard JensenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruitingBladder Cancer | Bladder Cancer, MetastaticDenmark
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
Brown UniversityLifespanTerminatedBladder Cancer | Invasive Bladder CancerUnited States
-
NYU Langone HealthWithdrawn
-
University of Rome Tor VergataCompletedSuperficial Bladder CancerItaly
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
Mansoura UniversityUnknownPain, Postoperative | Bladder Cancer | Flexible Cystoscopy | Non-muscle Invasive Bladder Cancer (NMIBC)Egypt
-
Incyte CorporationHoffmann-La Roche; Genentech, Inc.TerminatedUC (Urothelial Cancer) | NSCLC (Non-small Cell Lung Carcinoma)United States
-
National Taiwan University HospitalNational Taiwan UniversityRecruitingQuality of Life | Bladder CancerTaiwan
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
Turku University HospitalNordic Urothelial Cancer GroupRecruitingBladder Cancer | Invasive Bladder CancerFinland
-
Turku University HospitalNordic Urothelial Cancer GroupRecruitingBladder Cancer | Invasive Bladder CancerFinland
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; MFARActive, not recruiting
-
Eli Lilly and CompanyCompleted
-
Janssen Research & Development, LLCCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States
-
Applied Spectral Imaging Ltd.CompletedBladder CancersUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage III Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage IIIB Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8United States
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...WithdrawnMuscle-invasive Bladder CancerItaly
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group LimitedUnknownMuscle Invasive Bladder CancerChina
-
Seoul National University HospitalUnknownProstate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Masonic Cancer Center, University of MinnesotaBristol-Myers SquibbCompletedMuscle Invasive Bladder CancerUnited States
-
University of MiamiNational Cancer Institute (NCI)CompletedBladder Cancer Requiring CystectomyUnited States
-
The University of Texas Health Science Center at...TerminatedMuscle Invasive Bladder CancerUnited States
-
Institut BergoniéUnknownMuscle Invasive Bladder CancerFrance
-
Cairo UniversityCompleted
-
Early is Good Inc.RecruitingBladder CancerUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalNot yet recruitingSelf Efficacy | Smoking Behaviors | Progression, Disease | Non-Muscle Invasive Bladder Cancer | Tumor RecurrenceTurkey
-
Taris Biomedical LLCBristol-Myers SquibbTerminatedBladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditionsUnited States
-
Dr Anders UllénBayer; Pierre Fabre Laboratories; Nordic Urothelial Cancer Oncology GroupCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden